Daniel Grosslight
Stock Analyst at Citigroup
(1.44)
# 3,118
Out of 4,814 analysts
89
Total ratings
38.18%
Success rate
-10.14%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Buy | $13 → $11 | $6.65 | +65.41% | 6 | Apr 17, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Sell | $27 | $27.22 | -0.81% | 9 | Mar 6, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $120 → $129 | $134.68 | -4.21% | 5 | Jan 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $8.97 | +100.67% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.48 | +39.66% | 7 | Jan 10, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $11 → $10 | $3.85 | +159.74% | 8 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $697.08 | -2.88% | 7 | Jan 10, 2025 | |
| PHR Phreesia | Maintains: Buy | $31 → $35 | $23.94 | +46.20% | 6 | Jan 10, 2025 | |
| AGL agilon health | Upgrades: Neutral | $1.75 → $2.25 | $4.00 | -43.68% | 4 | Jan 10, 2025 | |
| PRVA Privia Health Group | Initiates: Buy | $25 | $23.68 | +5.57% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $6.83 | +178.18% | 10 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $5.91 | +69.35% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $7.78 | +2.83% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $3.24 | -61.42% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.67 | +31.09% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $7.82 | +66.24% | 1 | Dec 11, 2019 |
Owens & Minor
Apr 17, 2025
Maintains: Buy
Price Target: $13 → $11
Current: $6.65
Upside: +65.41%
Hims & Hers Health
Mar 6, 2025
Reiterates: Sell
Price Target: $27
Current: $27.22
Upside: -0.81%
Cardinal Health
Jan 10, 2025
Maintains: Neutral
Price Target: $120 → $129
Current: $134.68
Upside: -4.21%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $8.97
Upside: +100.67%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.48
Upside: +39.66%
Health Catalyst
Jan 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.85
Upside: +159.74%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $697.08
Upside: -2.88%
Phreesia
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $23.94
Upside: +46.20%
agilon health
Jan 10, 2025
Upgrades: Neutral
Price Target: $1.75 → $2.25
Current: $4.00
Upside: -43.68%
Privia Health Group
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $23.68
Upside: +5.57%
Feb 21, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $6.83
Upside: +178.18%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $5.91
Upside: +69.35%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $7.78
Upside: +2.83%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $3.24
Upside: -61.42%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.67
Upside: +31.09%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $7.82
Upside: +66.24%